Dong-Gyu Jo

Professor

Sungkyunkwan University

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dong-Gyu Jo is a Professor at Sungkyunkwan University in South Korea. His research interests encompass areas such as Alzheimer's disease, cancer therapies, and cellular mechanisms involved in aging. Recent publications include studies on the therapeutic potential of Ramalin derivatives and the role of extracellular vesicles in dermal regeneration. He is also engaged in investigating the molecular pathways of hypoxia and histone deacetylases in various diseases.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Seunglee Kwon

Sungkyunkwan University

SOUTH KOREA

View details

Thiruma Arumugam

Professor

La Trobe University

AUSTRALIA

View details

KI YOUNG CHOI

Assistant Professor

Gangneung-Wonju National University

SOUTH KOREA

View details

Jae Hyung Park

Sungkyunkwan University

SOUTH KOREA

View details

Youngdae Gwon

Assistant Professor

Sungkyunkwan University School of Medicine

SOUTH KOREA

View details

Wooram Um

Pusan National University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dong-Gyu Jo

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Hypoxia-mediated CRIP2 activation via NICD1 translocation regulates glycolysis and cell death

Synthesis and Biological Evaluation of Novel Ramalin Derivatives as Multi-Target Agents for Alzheimer’s Disease

Stem Cell-Derived Extracellular Vesicle-Bearing Injectable Hydrogel for Collagen Generation in Dermis

Synthesis and Evaluation of Chloride-Substituted Ramalin Derivatives for Alzheimer’s Disease Treatment

The Role of IRF9 Upregulation in Modulating Sensitivity to Olaparib and Platinum-Based Chemotherapies in Breast Cancer

Dysregulation of histone deacetylases in ocular diseases

Aging-associated sensory decline and Alzheimer’s disease

Therapeutic Potential of Ramalin Derivatives with Enhanced Stability in the Treatment of Alzheimer’s Disease

Targeting HIF-1α/NOTCH1 pathway eliminates CD44+ cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma

Stem Cell-Derived Extracellular Vesicle-Bearing Dermal Filler Ameliorates the Dermis Microenvironment by Supporting CD301b-Expressing Macrophages

Aberrant role of pyruvate kinase M2 in the regulation of gamma-secretase and memory deficits in Alzheimer’s disease

Correction to: Inhibitor of DNA binding 2 (Id2) mediates microtubule polymerization in the brain by regulating αK40 acetylation of α-tubulin

Inhibitor of DNA binding 2 (Id2) mediates microtubule polymerization in the brain by regulating αK40 acetylation of α-tubulin

Metabolically engineered stem cell–derived exosomes to regulate macrophage heterogeneity in rheumatoid arthritis

Correction to: White matter and neurological disorders

SERP1 is an assembly regulator of γ-secretase in metabolic stress conditions

White matter and neurological disorders

Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis

Collaborators (6)

Seunglee Kwon

Thiruma Arumugam

KI YOUNG CHOI

Jae Hyung Park

Youngdae Gwon

Wooram Um

Make your next move.